{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-005126","form_type":"8-K","ticker":"BPTH","cik":"0001133818","company_name":"BIO-PATH HOLDINGS, INC.","filed_at":"2022-04-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.851831+00:00","generated_at":"2026-06-26T09:01:28.292448+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Bio-Path appoints Aline Sherwood to board, regains Nasdaq compliance","bullets":["Aline Sherwood appointed to Bio-Path board effective March 31, 2022, filling vacancy left by Martina Molsbergen's Feb 14 resignation.","Sherwood named to audit, compensation, nominating/corporate governance, and business development committees.","Nasdaq notified company April 6, 2022 that board and audit committee now comply with listing rules 5605(b)(1) and 5605(c)(2)(A).","Sherwood is principal of Scienta Communications; previously managed communications at The Liposome Company and WeissComm Group."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-005126","json":"https://secwatch.observer/filing/0001558370-22-005126.json","markdown":"https://secwatch.observer/filing/0001558370-22-005126.md","text":"https://secwatch.observer/filing/0001558370-22-005126.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/0001558370-22-005126-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/bpth-20220331x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:01:28.292448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"02915037ed","claim":"Martina Molsbergen resigned as Director at BIO-PATH HOLDINGS, INC..","evidence_excerpt":"On February 14, 2022, Martina Molsbergen resigned from her position as a member of the Board of Directors (the “Board”) of Bio-Path Holdings, Inc. (the “Company”) and all committees of the Board on which she served.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/0001558370-22-005126-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ff1b893661","claim":"Aline Sherwood was appointed as Director at BIO-PATH HOLDINGS, INC..","evidence_excerpt":"On March 31, 2022, the Board appointed Aline Sherwood to the Board to fill the vacancy resulting from the resignation of Ms. Molsbergen.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/0001558370-22-005126-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}